Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Deluca

Showing results (241-250 of 270) with videos related to

Pageof 27
Sort By:
Contemporary Clinical Trials|November 10, 2019
Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosisBrian M Sandroff, M David Diggs, Marcas M Bamman, et al.
The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MSJohn DeLuca, Sven Schippling, Xavier Montalban, et al.
Contemporary Clinical Trials|September 21, 2023
The effects of cognitive rehabilitation combined with aerobic exercise or stretching-and-toning on new learning and memory in persons with moderate-to-severe TBI: Protocol for a randomized controlled trialBrian M Sandroff, Erica Weber, Glenn R Wylie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2019
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic reviewCurtis M Wojcik, Meghan Beier, Kathleen Costello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
The Clinical Neuropsychologist|June 10, 2016
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)Elizabeth S Gromisch, Vance Zemon, Roee Holtzer, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.
Pageof 27

Showing results (241-250 of 270) with videos related to

Sort By:
Pageof 27
Contemporary Clinical Trials|November 10, 2019
Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosisBrian M Sandroff, M David Diggs, Marcas M Bamman, et al.
The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Multiple Sclerosis and Related Disorders|January 17, 2021
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MSJohn DeLuca, Sven Schippling, Xavier Montalban, et al.
Contemporary Clinical Trials|September 21, 2023
The effects of cognitive rehabilitation combined with aerobic exercise or stretching-and-toning on new learning and memory in persons with moderate-to-severe TBI: Protocol for a randomized controlled trialBrian M Sandroff, Erica Weber, Glenn R Wylie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2019
Computerized neuropsychological assessment devices in multiple sclerosis: A systematic reviewCurtis M Wojcik, Meghan Beier, Kathleen Costello, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 11, 2018
Recommendations for cognitive screening and management in multiple sclerosis careRosalind Kalb, Meghan Beier, Ralph Hb Benedict, et al.
The Clinical Neuropsychologist|June 10, 2016
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)Elizabeth S Gromisch, Vance Zemon, Roee Holtzer, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Journal of Neurology|August 20, 2020
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosisNancy D Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.
Pageof 27